COVID-19 vaccines: A race against time

Anaesth Crit Care Pain Med. 2021 Apr;40(2):100848. doi: 10.1016/j.accpm.2021.100848. Epub 2021 Mar 24.

¹ Infectious Diseases Department, Bichat-Claude Bernard Hospital, Assistance-Publique Hôpitaux de Paris, Paris, France; Université de Paris, INSERM, IAME, F-75006 Paris, France; National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, United Kingdom. Electronic address: Nathan.peiffer-smadja@aphp.fr.
² Department of Anaesthesiology and Critical Care Medicine, Bichat-Claude Bernard Hospital, Assistance-Publique Hôpitaux de Paris, Paris, France; Université de Paris, Paris, France.
³ Infectious Diseases Department, Bichat-Claude Bernard Hospital, Assistance-Publique Hôpitaux de Paris, Paris, France; Université de Paris, Paris, France.
⁴ Infectious Diseases Department, Bichat-Claude Bernard Hospital, Assistance-Publique Hôpitaux de Paris, Paris, France; Université de Paris, INSERM, IAME, F-75006 Paris, France.
⁵ Department of Anaesthesiology and Critical Care Medicine, Bichat-Claude Bernard Hospital, Assistance-Publique Hôpitaux de Paris, Paris, France; Université de Paris, Paris, France; INSERM UMR1152, ANR-10-LABX-17, Paris, France.

No abstract available

Keywords: COVID-19; Efficacy; SARS-CoV-2; Safety; Vaccination; Variants.

Publication types